Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (191-200 of 270) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2017
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Alexander W Wyatt, Edmund C Chedgy, et al.
Oncotarget|December 30, 2014
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancerDong Lin, Xin Dong, Kendric Wang, et al.
The Journal of Pathology|July 18, 2018
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinomaEdmund Cp Chedgy, Gillian Vandekerkhove, Cameron Herberts, et al.
Journal of the National Cancer Institute|September 7, 2023
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trialTakayuki Sumiyoshi, Xiaofei Wang, Evan W Warner, et al.
Medical Image Analysis|October 20, 2018
Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple expertsGuy Nir, Soheil Hor, Davood Karimi, et al.
Communications Biology|January 18, 2024
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
Cancer Research|June 29, 2021
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease ProgressionNora Pällmann, Ke Deng, Marte Livgård, et al.
Molecular Cell|January 27, 2020
Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28Ines Müller, Elwira Strozyk, Sebastian Schindler, et al.
EMBO Molecular Medicine|February 15, 2015
STAMP2 increases oxidative stress and is critical for prostate cancerYang Jin, Ling Wang, Su Qu, et al.
Pageof 27

Showing results (191-200 of 270) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2017
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Alexander W Wyatt, Edmund C Chedgy, et al.
Oncotarget|December 30, 2014
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancerDong Lin, Xin Dong, Kendric Wang, et al.
The Journal of Pathology|July 18, 2018
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinomaEdmund Cp Chedgy, Gillian Vandekerkhove, Cameron Herberts, et al.
Journal of the National Cancer Institute|September 7, 2023
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trialTakayuki Sumiyoshi, Xiaofei Wang, Evan W Warner, et al.
Medical Image Analysis|October 20, 2018
Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple expertsGuy Nir, Soheil Hor, Davood Karimi, et al.
Communications Biology|January 18, 2024
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
Cancer Research|June 29, 2021
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease ProgressionNora Pällmann, Ke Deng, Marte Livgård, et al.
Molecular Cell|January 27, 2020
Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28Ines Müller, Elwira Strozyk, Sebastian Schindler, et al.
EMBO Molecular Medicine|February 15, 2015
STAMP2 increases oxidative stress and is critical for prostate cancerYang Jin, Ling Wang, Su Qu, et al.
Pageof 27